430 related articles for article (PubMed ID: 14638868)
1. Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR.
Shtivelman E
Mol Cancer Res; 2003 Nov; 1(13):959-69. PubMed ID: 14638868
[TBL] [Abstract][Full Text] [Related]
2. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
[TBL] [Abstract][Full Text] [Related]
3. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.
Kang D; Chen J; Wong J; Fang G
J Cell Biol; 2002 Jan; 156(2):249-59. PubMed ID: 11807090
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
Tsvetkov L; Stern DF
Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
[TBL] [Abstract][Full Text] [Related]
5. Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and modulates the association of spindle-checkpoint proteins at kinetochores.
Ahonen LJ; Kallio MJ; Daum JR; Bolton M; Manke IA; Yaffe MB; Stukenberg PT; Gorbsky GJ
Curr Biol; 2005 Jun; 15(12):1078-89. PubMed ID: 15964272
[TBL] [Abstract][Full Text] [Related]
6. CHFR-associated early G2/M checkpoint defects in breast cancer cells.
Erson AE; Petty EM
Mol Carcinog; 2004 Jan; 39(1):26-33. PubMed ID: 14694445
[TBL] [Abstract][Full Text] [Related]
7. Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation.
Chen J; Dai G; Wang YQ; Wang S; Pan FY; Xue B; Zhao DH; Li CJ
FEBS Lett; 2006 Jun; 580(15):3624-30. PubMed ID: 16753148
[TBL] [Abstract][Full Text] [Related]
8. Purification and proteomic identification of putative upstream regulators of polo-like kinase-1 from mitotic cell extracts.
Ji JH; Hwang HI; Lee HJ; Hyun SY; Kang HJ; Jang YJ
FEBS Lett; 2010 Oct; 584(20):4299-305. PubMed ID: 20869364
[TBL] [Abstract][Full Text] [Related]
9. The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells.
Kim JS; Park YY; Park SY; Cho H; Kang D; Cho H
J Biol Chem; 2011 Sep; 286(35):30615-30623. PubMed ID: 21768102
[TBL] [Abstract][Full Text] [Related]
10. Getting in and out of mitosis with Polo-like kinase-1.
van Vugt MA; Medema RH
Oncogene; 2005 Apr; 24(17):2844-59. PubMed ID: 15838519
[TBL] [Abstract][Full Text] [Related]
11. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.
Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK
Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
13. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
[TBL] [Abstract][Full Text] [Related]
14. On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression.
Mundt KE; Golsteyn RM; Lane HA; Nigg EA
Biochem Biophys Res Commun; 1997 Oct; 239(2):377-85. PubMed ID: 9344838
[TBL] [Abstract][Full Text] [Related]
15. Integrated computational model of cell cycle and checkpoint reveals different essential roles of Aurora-A and Plk1 in mitotic entry.
Zou J; Luo SD; Wei YQ; Yang SY
Mol Biosyst; 2011 Jan; 7(1):169-79. PubMed ID: 20978655
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A.
Jang YJ; Ji JH; Choi YC; Ryu CJ; Ko SY
J Biol Chem; 2007 Jan; 282(4):2473-82. PubMed ID: 17121863
[TBL] [Abstract][Full Text] [Related]
18. Polo-like kinase 1 reaches beyond mitosis--cytokinesis, DNA damage response, and development.
Takaki T; Trenz K; Costanzo V; Petronczki M
Curr Opin Cell Biol; 2008 Dec; 20(6):650-60. PubMed ID: 19000759
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia.
Didier C; Cavelier C; Quaranta M; Demur C; Ducommun B
Eur J Pharmacol; 2008 Sep; 591(1-3):102-5. PubMed ID: 18616938
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of DNA-dependent protein kinase leads to spindle disruption and mitotic catastrophe with attenuated checkpoint protein 2 Phosphorylation in response to DNA damage.
Shang ZF; Huang B; Xu QZ; Zhang SM; Fan R; Liu XD; Wang Y; Zhou PK
Cancer Res; 2010 May; 70(9):3657-66. PubMed ID: 20406977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]